Literature / Brochures
Formulation Development
Syngene supports both development and manufacturing of Drug Products from early to late stage.
Formulation Development
Capabilities
-
Preformulation profiling including Salt and Polymorph screening
-
Preclinical formulation development
-
Drug-drug and drug-excipient compatibility study
-
Formulation development – Oral solids, Liquids, Semisolids, Injectables (OEL up to 1 µg/m³)
-
Ready to use and Lyophilized injectable product development, including nanosuspensions
-
High potent Injectable dosage form development
DOWNLOAD TO LEARN MORE>>>>
More Literature / Brochures by Syngene
More Content From Syngene
-
At Syngene, we have developed a roadmap across pre-IND, IND and NDA that seamlessly integrate the various pre-clinical studies.
-
Outsourcing answer to the innovation and ROI challenge in the Biopharmaceutical Industry.
-
By identifying COVID-19 positive cases early on, particularly those that are asymptomatic, we can restrict further transmission of this deadly virus.
-
Syngene's 7-phase integrated CMC strategy helps expedite IND/IMPD filings and FIH studies.
-
Read how Syngene's partnership with a leading Biotech company working in the field of cancer therapy grew from one small pilot project to over 100 FTEs today.
-
-
Learn why Baxter chose to partner with Syngene for Stability studies, the business flow, governance mechanism and metrics that were implemented.
-
-
-
Press Trust of India | New Delhi
-
The consortium brings together a diverse group of companies with synergistic areas of expertise
-
